• レポートコード:MRC2-11QY04433 • 出版社/出版日:QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態:英文、PDF、94ページ • 納品方法:Eメール(納期:2~3日) • 産業分類:ヘルスケア |
Single User | ¥585,000 (USD3,900) | ▷ お問い合わせ |
Multi User | ¥877,500 (USD5,850) | ▷ お問い合わせ |
Enterprise License | ¥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はキノロン抗生物質のグローバル市場について調査・分析したレポートです。種類別(シプロフロキサシン、レボフロキサシン、ガチフロキサシン、モキシフロキサシン、オフロキサシン、ノルフロキサシン、その他)市場規模、用途別(病院・診療所、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別キノロン抗生物質の競争状況、市場シェア ・世界のキノロン抗生物質市場:種類別市場規模 2015年-2020年(シプロフロキサシン、レボフロキサシン、ガチフロキサシン、モキシフロキサシン、オフロキサシン、ノルフロキサシン、その他) ・世界のキノロン抗生物質市場:種類別市場規模予測 2021年-2026年(シプロフロキサシン、レボフロキサシン、ガチフロキサシン、モキシフロキサシン、オフロキサシン、ノルフロキサシン、その他) ・世界のキノロン抗生物質市場:用途別市場規模 2015年-2020年(病院・診療所、その他) ・世界のキノロン抗生物質市場:用途別市場規模予測 2021年-2026年(病院・診療所、その他) ・北米のキノロン抗生物質市場分析:米国、カナダ ・ヨーロッパのキノロン抗生物質市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのキノロン抗生物質市場分析:日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のキノロン抗生物質市場分析:メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのキノロン抗生物質市場分析:トルコ、サウジアラビア、UAE等 ・企業情報(企業概要、製品概要、販売量、企業動向) - 掲載企業(変更可能性あり):Healthy Life Pharma、Mercury Medicare、Merck、Tianjin Glory Technology、Hebei Guangren Pharmaceutical Technology ・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
A Quinolone Antibiotic is any member of a large group of broad-spectrum bactericides that share a bicyclic core structure related to the compound 4-quinolone. They are used in human and veterinary medicine to treat bacterial infections, as well as in animal husbandry.
Nearly all quinolone antibiotics in use are fluoroquinolones, which contain a fluorine atom in their chemical structure and are effective against both Gram-negative and Gram-positive bacteria. One example is ciprofloxacin, one of the most widely used antibiotics worldwide.
Market Analysis and Insights: Global Quinolone Antibiotic Market
The global Quinolone Antibiotic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Quinolone Antibiotic Scope and Market Size
Quinolone Antibiotic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Quinolone Antibiotic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Healthy Life Pharma
Mercury Medicare
Merck
Tianjin Glory Technology
Hebei Guangren Pharmaceutical Technology
…
Market segment by Type, the product can be split into
Ciprofloxacin
Levofloxacin
Gatifloxacin
Moxifloxacin
Ofloxacin
Norfloxacin
Others
Market segment by Application, split into
Hosptials and Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Quinolone Antibiotic Revenue
1.4 Market by Type
1.4.1 Global Quinolone Antibiotic Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ciprofloxacin
1.4.3 Levofloxacin
1.4.4 Gatifloxacin
1.4.5 Moxifloxacin
1.4.6 Ofloxacin
1.4.7 Norfloxacin
1.4.8 Others
1.5 Market by Application
1.5.1 Global Quinolone Antibiotic Market Share by Application: 2020 VS 2026
1.5.2 Hosptials and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Quinolone Antibiotic Market Perspective (2015-2026)
2.2 Global Quinolone Antibiotic Growth Trends by Regions
2.2.1 Quinolone Antibiotic Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Quinolone Antibiotic Historic Market Share by Regions (2015-2020)
2.2.3 Quinolone Antibiotic Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Quinolone Antibiotic Market Growth Strategy
2.3.6 Primary Interviews with Key Quinolone Antibiotic Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Quinolone Antibiotic Players by Market Size
3.1.1 Global Top Quinolone Antibiotic Players by Revenue (2015-2020)
3.1.2 Global Quinolone Antibiotic Revenue Market Share by Players (2015-2020)
3.1.3 Global Quinolone Antibiotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Quinolone Antibiotic Market Concentration Ratio
3.2.1 Global Quinolone Antibiotic Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Quinolone Antibiotic Revenue in 2019
3.3 Quinolone Antibiotic Key Players Head office and Area Served
3.4 Key Players Quinolone Antibiotic Product Solution and Service
3.5 Date of Enter into Quinolone Antibiotic Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Quinolone Antibiotic Historic Market Size by Type (2015-2020)
4.2 Global Quinolone Antibiotic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Quinolone Antibiotic Market Size by Application (2015-2020)
5.2 Global Quinolone Antibiotic Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Quinolone Antibiotic Market Size (2015-2020)
6.2 Quinolone Antibiotic Key Players in North America (2019-2020)
6.3 North America Quinolone Antibiotic Market Size by Type (2015-2020)
6.4 North America Quinolone Antibiotic Market Size by Application (2015-2020)
7 Europe
7.1 Europe Quinolone Antibiotic Market Size (2015-2020)
7.2 Quinolone Antibiotic Key Players in Europe (2019-2020)
7.3 Europe Quinolone Antibiotic Market Size by Type (2015-2020)
7.4 Europe Quinolone Antibiotic Market Size by Application (2015-2020)
8 China
8.1 China Quinolone Antibiotic Market Size (2015-2020)
8.2 Quinolone Antibiotic Key Players in China (2019-2020)
8.3 China Quinolone Antibiotic Market Size by Type (2015-2020)
8.4 China Quinolone Antibiotic Market Size by Application (2015-2020)
9 Japan
9.1 Japan Quinolone Antibiotic Market Size (2015-2020)
9.2 Quinolone Antibiotic Key Players in Japan (2019-2020)
9.3 Japan Quinolone Antibiotic Market Size by Type (2015-2020)
9.4 Japan Quinolone Antibiotic Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Quinolone Antibiotic Market Size (2015-2020)
10.2 Quinolone Antibiotic Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Quinolone Antibiotic Market Size by Type (2015-2020)
10.4 Southeast Asia Quinolone Antibiotic Market Size by Application (2015-2020)
11 India
11.1 India Quinolone Antibiotic Market Size (2015-2020)
11.2 Quinolone Antibiotic Key Players in India (2019-2020)
11.3 India Quinolone Antibiotic Market Size by Type (2015-2020)
11.4 India Quinolone Antibiotic Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Quinolone Antibiotic Market Size (2015-2020)
12.2 Quinolone Antibiotic Key Players in Central & South America (2019-2020)
12.3 Central & South America Quinolone Antibiotic Market Size by Type (2015-2020)
12.4 Central & South America Quinolone Antibiotic Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Healthy Life Pharma
13.1.1 Healthy Life Pharma Company Details
13.1.2 Healthy Life Pharma Business Overview
13.1.3 Healthy Life Pharma Quinolone Antibiotic Introduction
13.1.4 Healthy Life Pharma Revenue in Quinolone Antibiotic Business (2015-2020))
13.1.5 Healthy Life Pharma Recent Development
13.2 Mercury Medicare
13.2.1 Mercury Medicare Company Details
13.2.2 Mercury Medicare Business Overview
13.2.3 Mercury Medicare Quinolone Antibiotic Introduction
13.2.4 Mercury Medicare Revenue in Quinolone Antibiotic Business (2015-2020)
13.2.5 Mercury Medicare Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Quinolone Antibiotic Introduction
13.3.4 Merck Revenue in Quinolone Antibiotic Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Tianjin Glory Technology
13.4.1 Tianjin Glory Technology Company Details
13.4.2 Tianjin Glory Technology Business Overview
13.4.3 Tianjin Glory Technology Quinolone Antibiotic Introduction
13.4.4 Tianjin Glory Technology Revenue in Quinolone Antibiotic Business (2015-2020)
13.4.5 Tianjin Glory Technology Recent Development
13.5 Hebei Guangren Pharmaceutical Technology
13.5.1 Hebei Guangren Pharmaceutical Technology Company Details
13.5.2 Hebei Guangren Pharmaceutical Technology Business Overview
13.5.3 Hebei Guangren Pharmaceutical Technology Quinolone Antibiotic Introduction
13.5.4 Hebei Guangren Pharmaceutical Technology Revenue in Quinolone Antibiotic Business (2015-2020)
13.5.5 Hebei Guangren Pharmaceutical Technology Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Quinolone Antibiotic Key Market Segments
Table 2. Key Players Covered: Ranking by Quinolone Antibiotic Revenue
Table 3. Ranking of Global Top Quinolone Antibiotic Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Quinolone Antibiotic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ciprofloxacin
Table 6. Key Players of Levofloxacin
Table 7. Key Players of Gatifloxacin
Table 8. Key Players of Moxifloxacin
Table 9. Key Players of Ofloxacin
Table 10. Key Players of Norfloxacin
Table 11. Key Players of Others
Table 12. Global Quinolone Antibiotic Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Quinolone Antibiotic Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Quinolone Antibiotic Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Quinolone Antibiotic Market Share by Regions (2015-2020)
Table 16. Global Quinolone Antibiotic Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Quinolone Antibiotic Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Quinolone Antibiotic Market Growth Strategy
Table 22. Main Points Interviewed from Key Quinolone Antibiotic Players
Table 23. Global Quinolone Antibiotic Revenue by Players (2015-2020) (Million US$)
Table 24. Global Quinolone Antibiotic Market Share by Players (2015-2020)
Table 25. Global Top Quinolone Antibiotic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Quinolone Antibiotic as of 2019)
Table 26. Global Quinolone Antibiotic by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Quinolone Antibiotic Product Solution and Service
Table 29. Date of Enter into Quinolone Antibiotic Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Quinolone Antibiotic Market Size by Type (2015-2020) (Million US$)
Table 32. Global Quinolone Antibiotic Market Size Share by Type (2015-2020)
Table 33. Global Quinolone Antibiotic Revenue Market Share by Type (2021-2026)
Table 34. Global Quinolone Antibiotic Market Size Share by Application (2015-2020)
Table 35. Global Quinolone Antibiotic Market Size by Application (2015-2020) (Million US$)
Table 36. Global Quinolone Antibiotic Market Size Share by Application (2021-2026)
Table 37. North America Key Players Quinolone Antibiotic Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Quinolone Antibiotic Market Share (2019-2020)
Table 39. North America Quinolone Antibiotic Market Size by Type (2015-2020) (Million US$)
Table 40. North America Quinolone Antibiotic Market Share by Type (2015-2020)
Table 41. North America Quinolone Antibiotic Market Size by Application (2015-2020) (Million US$)
Table 42. North America Quinolone Antibiotic Market Share by Application (2015-2020)
Table 43. Europe Key Players Quinolone Antibiotic Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Quinolone Antibiotic Market Share (2019-2020)
Table 45. Europe Quinolone Antibiotic Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Quinolone Antibiotic Market Share by Type (2015-2020)
Table 47. Europe Quinolone Antibiotic Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Quinolone Antibiotic Market Share by Application (2015-2020)
Table 49. China Key Players Quinolone Antibiotic Revenue (2019-2020) (Million US$)
Table 50. China Key Players Quinolone Antibiotic Market Share (2019-2020)
Table 51. China Quinolone Antibiotic Market Size by Type (2015-2020) (Million US$)
Table 52. China Quinolone Antibiotic Market Share by Type (2015-2020)
Table 53. China Quinolone Antibiotic Market Size by Application (2015-2020) (Million US$)
Table 54. China Quinolone Antibiotic Market Share by Application (2015-2020)
Table 55. Japan Key Players Quinolone Antibiotic Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Quinolone Antibiotic Market Share (2019-2020)
Table 57. Japan Quinolone Antibiotic Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Quinolone Antibiotic Market Share by Type (2015-2020)
Table 59. Japan Quinolone Antibiotic Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Quinolone Antibiotic Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Quinolone Antibiotic Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Quinolone Antibiotic Market Share (2019-2020)
Table 63. Southeast Asia Quinolone Antibiotic Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Quinolone Antibiotic Market Share by Type (2015-2020)
Table 65. Southeast Asia Quinolone Antibiotic Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Quinolone Antibiotic Market Share by Application (2015-2020)
Table 67. India Key Players Quinolone Antibiotic Revenue (2019-2020) (Million US$)
Table 68. India Key Players Quinolone Antibiotic Market Share (2019-2020)
Table 69. India Quinolone Antibiotic Market Size by Type (2015-2020) (Million US$)
Table 70. India Quinolone Antibiotic Market Share by Type (2015-2020)
Table 71. India Quinolone Antibiotic Market Size by Application (2015-2020) (Million US$)
Table 72. India Quinolone Antibiotic Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Quinolone Antibiotic Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Quinolone Antibiotic Market Share (2019-2020)
Table 75. Central & South America Quinolone Antibiotic Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Quinolone Antibiotic Market Share by Type (2015-2020)
Table 77. Central & South America Quinolone Antibiotic Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Quinolone Antibiotic Market Share by Application (2015-2020)
Table 79. Healthy Life Pharma Company Details
Table 80. Healthy Life Pharma Business Overview
Table 81. Healthy Life Pharma Product
Table 82. Healthy Life Pharma Revenue in Quinolone Antibiotic Business (2015-2020) (Million US$)
Table 83. Healthy Life Pharma Recent Development
Table 84. Mercury Medicare Company Details
Table 85. Mercury Medicare Business Overview
Table 86. Mercury Medicare Product
Table 87. Mercury Medicare Revenue in Quinolone Antibiotic Business (2015-2020) (Million US$)
Table 88. Mercury Medicare Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Quinolone Antibiotic Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Tianjin Glory Technology Company Details
Table 95. Tianjin Glory Technology Business Overview
Table 96. Tianjin Glory Technology Product
Table 97. Tianjin Glory Technology Revenue in Quinolone Antibiotic Business (2015-2020) (Million US$)
Table 98. Tianjin Glory Technology Recent Development
Table 99. Hebei Guangren Pharmaceutical Technology Company Details
Table 100. Hebei Guangren Pharmaceutical Technology Business Overview
Table 101. Hebei Guangren Pharmaceutical Technology Product
Table 102. Hebei Guangren Pharmaceutical Technology Revenue in Quinolone Antibiotic Business (2015-2020) (Million US$)
Table 103. Hebei Guangren Pharmaceutical Technology Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Quinolone Antibiotic Market Share by Type: 2020 VS 2026
Figure 2. Ciprofloxacin Features
Figure 3. Levofloxacin Features
Figure 4. Gatifloxacin Features
Figure 5. Moxifloxacin Features
Figure 6. Ofloxacin Features
Figure 7. Norfloxacin Features
Figure 8. Others Features
Figure 9. Global Quinolone Antibiotic Market Share by Application: 2020 VS 2026
Figure 10. Hosptials and Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Quinolone Antibiotic Report Years Considered
Figure 13. Global Quinolone Antibiotic Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Quinolone Antibiotic Market Share by Regions: 2020 VS 2026
Figure 15. Global Quinolone Antibiotic Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Quinolone Antibiotic Market Share by Players in 2019
Figure 18. Global Top Quinolone Antibiotic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Quinolone Antibiotic as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Quinolone Antibiotic Revenue in 2019
Figure 20. North America Quinolone Antibiotic Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Quinolone Antibiotic Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Quinolone Antibiotic Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Quinolone Antibiotic Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Quinolone Antibiotic Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Quinolone Antibiotic Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Quinolone Antibiotic Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed